IRUS Total

Code-sharing in cost-of-illness calculations: an application to antibiotic-resistant bloodstream infections

File Description SizeFormat 
fpubh-08-562427.pdfPublished version1.22 MBAdobe PDFView/Open
Title: Code-sharing in cost-of-illness calculations: an application to antibiotic-resistant bloodstream infections
Authors: Naylor, N
Yamashita, K
Iwami, M
Kunisawa, S
Mizuno, S
Castro-Sánchez, E
Imanaka, Y
Ahmad, R
Holmes, A
Item Type: Journal Article
Abstract: Background: More data-driven evidence is needed on the cost of antibiotic resistance. Both Japan and England have large surveillance and administrative datasets. Code sharing of costing models enables reduced duplication of effort in research. Objective: To estimate the burden of antibiotic-resistant Staphylococcus aureus bloodstream infections (BSIs) in Japan, utilizing code that was written to estimate the hospital burden of antibiotic-resistant Escherichia coli BSIs in England. Additionally, the process in which the code-sharing and application was performed is detailed, to aid future such use of code-sharing in health economics. Methods: National administrative data sources were linked with voluntary surveillance data within the Japan case study. R software code, which created multistate models to estimate the excess length of stay associated with different exposures of interest, was adapted from previous use and run on this dataset. Unit costs were applied to estimate healthcare system burden in 2017 international dollars (I$). Results: Clear supporting documentation alongside open-access code, licensing, and formal communication channels, helped the re-application of costing code from the English setting within the Japanese setting. From the Japanese healthcare system perspective, it was estimated that there was an excess cost of I$6,392 per S. aureus BSI, whilst oxacillin resistance was associated with an additional I$8,155. Conclusions: S. aureus resistance profiles other than methicillin may substantially impact hospital costs. The sharing of costing models within the field of antibiotic resistance is a feasible way to increase burden evidence efficiently, allowing for decision makers (with appropriate data available) to gain rapid cost-of-illness estimates.
Issue Date: 27-Nov-2020
Date of Acceptance: 13-Oct-2020
URI: http://hdl.handle.net/10044/1/84790
DOI: 10.3389/fpubh.2020.562427
ISSN: 2296-2565
Publisher: Frontiers Media
Journal / Book Title: Frontiers in Public Health
Volume: 8
Copyright Statement: © 2020 Naylor, Yamashita, Iwami, Kunisawa, Mizuno, Castro-Sánchez, Imanaka, Ahmad and Holmes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Sponsor/Funder: National Institute for Health Research
National Institute for Health Research
Funder's Grant Number: HPRU-2012-10047
Keywords: 1117 Public Health and Health Services
Publication Status: Published
Article Number: ARTN 562427
Appears in Collections:Department of Infectious Diseases

This item is licensed under a Creative Commons License Creative Commons